Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Shadow Of 2003: Hatch/Waxman Changes May Join Health Reform Bills

Executive Summary

The Medicare drug benefit, created in 2003, is casting a long shadow on the health care reform debate of 2009

You may also be interested in...



Brand/Generic Settlement Bill Advances; Will Debate Come Down To FTC v. CBO?

After clearing the Senate Judiciary Committee on Oct. 15, the next hurdle for legislation that would curtail settlement deals between brand firms and generic challengers may be obtaining a favorable score from the Congressional Budget Office

Brand/Generic Settlement Bill Advances; Will Debate Come Down To FTC v. CBO?

After clearing the Senate Judiciary Committee on Oct. 15, the next hurdle for legislation that would curtail settlement deals between brand firms and generic challengers may be obtaining a favorable score from the Congressional Budget Office

Teva Settlements Stick To Date of Entry Even As Legislative Debate Continues

Teva is taking a cautious approach in its patent settlements with brand firms - inking deals that meet the strict standards of pending legislation even as the bills are still under debate

Related Content

Topics

UsernamePublicRestriction

Register

PS078529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel